NCT00006013已完成2 期
Phase II Trial of SU5416 as Treatment for Refractory/Relapsed Multiple Myeloma
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 21
- 试验地点
- 8
研究概览
简要总结
RATIONALE: SU5416 may stop the growth of multiple myeloma by stopping blood flow to the cancer cells.
PURPOSE: Phase II trial to study the effectiveness of SU5416 in treating patients who have refractory or relapsed multiple myeloma.
详细描述
OBJECTIVES: I. Determine the response rate and response duration of patients with refractory or relapsed multiple myeloma treated with SU5416. II. Determine the toxicity of SU5416 in this patient population.
OUTLINE: This is a multicenter study. Patients receive SU5416 IV over 1 hour twice weekly. Treatment continues in the absence of unacceptable toxicity or disease progression. Patients are followed for survival.
PROJECTED ACCRUAL: A total of 20-38 patients will be accrued for this study within 2 years.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (8)
Loading locations...
相似试验
终止
2 期
SU5416 in Treating Patients With Metastatic Melanoma That Has Been Previously TreatedRecurrent MelanomaStage IV MelanomaNCT00006003National Cancer Institute (NCI)35
已完成
1 期
SU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not Responded to Radiation TherapyBrain and Central Nervous System TumorsNCT00004868Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
已完成
2 期
SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and NeckCarcinoma of Unknown PrimaryHead and Neck CancerNon-melanomatous Skin CancerNCT00006361Memorial Sloan Kettering Cancer Center
已完成
1 期
SU5416 and Paclitaxel in Treating Patients With Advanced CancerUnspecified Adult Solid Tumor, Protocol SpecificNCT00006257City of Hope Medical Center
已完成
2 期
SU5416 and Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney CancerKidney CancerNCT00006384City of Hope Medical Center